Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUMSCs-Exo for Vitiligo
NCT07519031Phase 2Not yet recruiting
- Sponsor
- Xijing Hospital
- Start
- Apr 2026
- Primary completion
- Nov 2027
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cell-derived exosomes in Vitiligo, sponsored by Xijing Hospital. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cell-derived exosomes
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07519031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07519031.